Skip to content

10x Genomics, Inc. TXG Lease Liability Payments - Due Year Two

Lease Liability Payments - Due Year Two at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$12.57M+50.2%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$362K
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s lease liability payments - due year two.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s lease liability payments - due year two?
10x Genomics, Inc. (TXG) reported lease liability payments - due year two of $16.38M in Q1 2026.
How has 10x Genomics, Inc.'s lease liability payments - due year two changed year-over-year?
10x Genomics, Inc.'s lease liability payments - due year two increased by 5.1% year-over-year, from $15.59M to $16.38M.
What does lease liability payments - due year two mean?
This metric identifies the total cash payments required for operating and finance leases in the second year following the current balance sheet date. It helps investors forecast long-term fixed cost commitments and cash flow requirements. It is essential for modeling the company's future solvency and operational leverage.